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A method detects binding of molecules, advantageously 
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the sensor is exposed to a biological sample for sufficient 
time for its single stranded nucleic acid sequence to bind to 
a material of interest, photoluminescence from the sensor 
can be measured. An apparatus for tagging-free detection of 
binding of molecules also is provided. Methods of making 
tagging-free sensors are provided. Also, tagging-free meth- 
ods to detect binding of antigens and related devices are 
disclosed. 
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BIO-CHIP, PHOTOLUMINESCENT functional study (such as mutation, gene expression) of 
METHODS FOR IDENTIFYING genetic code, understanding various biological mechanisms, 
BIOLOGICAL MATERIAL, AND crime detection, etc. Although advances in DNA sequencing 
APPARATUSES FOR USE WITH SUCH and other protein sequencing technologies have been made 
METHODS AND BIO-CHIPS s in recent years, such procedures still limit and delay workers 
in the art awaiting sequencing results. Those whose work 
This application claims the benefit of provision applica- relies on DNA sequencing and other protein sequencing 
tions Nos. 601286,525 filed Apr. 27, 2001 and 601237,677 would be helped by expedited rapidity of sequencing, sim- 
filed Oct. 5, 2000. plified sequencing, andlor enhanced precision and accuracy. 
10 Also, a small portable device useable in a doctor's office to 
FIELD OF THE INVENTION check, for example, if a patient may eventually develop 
The invention generally relates to nucleic acid, and more cancer Or how fast the is likely to break down a 'pecific 
particularly, to binding of single stranded nucleic acid with anti-cancer drug have been generally theorized as of interest. 
biological material of interest in a sample to identify the For all these applications, a tool that can perform a nucleic 
material. IS acid analysis of a small size sample for several specific 
genes (at low concentrations) is highly desirable, but not 
BACKGROUND OF THE INVENTION conventionally provided. Rather, the conventional bio-chip 
. A 
methods undesirably require tagging of the sample plus 
acids such as deox~ribonucleic acid (DNA), 
other disadvantages (such as expensive manufacturing 
ribOnucleic acid (RNA) and protein acid (PNA) are 20 
uncertainty in the number of fragments per pixel, fundamental components of matter of living organisms. 
etc,), Nucleic acids generally speaking consist of certain constitu- 
ent parts, or base pairs. The permutations in which these SUMMARY OF THE INVENTION 
base pairs may be arranged is vast. Nucleic acid sequence 
analysis, i.e., determining the identity and sequence of the It therefore is an object of this invention to provide 
base pairs of a nucleic acid sample, is an important tech- 25 methods and products for detecting the hybridization state of 
nology. Deciphering nucleic acid sequences is important for a nucleic acid molecule, without needing to tag the sample. 
disease diagnosis, drug design and understanding of various The invention can be used to perform sequence analysis of 
biological mechanisms. Before 1996, traditional methods unknown nucleic acids, such as DNA sequences. Several 
laboriously ' ' reap the gene sequencing one base pair at a genes can be probed simultaneously. Sequencing according 
time. 30 to the invention is relatively simple and quick, while pro- 
~~~~~d 1996, mymetr ix  developed a massively viding precise and accurate sequencing information. The 
sequencing approach, using a DNA chip with which several invention provides a bio-chip and other products for simul- 
base pairs can be read simultaneously. A monolayer of taneously analyzing one or more specific nucleic acid frag- 
specific single stranded DNA (ssDNA) fragments is 35 ments (such as genes) in a 
assembled on an array of pixels (-1-100,um2). The type of In order to accomplish these and other objects of the 
ssDNA may change from pixel to pixel. These ssDNA invention, the present invention in a preferred embodiment 
fragments act as "chemical tweezers" to pick the specific provides a tagging-free method to detect binding of 
complementary tagged ssDNA from the sample to form molecules, comprising the steps of: (A) providing a sensor 
double stranded DNA(dsDNA), i.e., a hybridization process 40 comprised of a first layer including a single stranded nucleic 
occurs. The hybridized region is observed by a fluorescent acid sequence and a second layer including a photolumi- 
label applied to the DNA in the sample before exposure to nescent material; (B) exposing said sensor to a biological 
the ssDNA probe fragments. The process is speedier than sample for sufficient time for said single stranded nucleic 
single-base-pair methods, is specific, can analyze multiple acid sequence to bind to a material of interest in said 
nucleotide sequences, simultaneously can process hundreds 45 biological sample; (C) exposing said sensor to light and 
of gene sequences and their alterations, and uses advanta- measuring photoluminescence from said sensor. In a par- 
geously small chips. Practical applications of the parallel ticularly preferred inventive tagging-free method, the mea- 
sequencing technology include: Affymetrix' study of p53 suring step includes sensing photoluminescent light from the 
gene malfunction (i.e., mutation) responsible for cancer second layer when ultraviolet light with wavelength in the 
(especially breast cancer); Merck's study of changes in DNA range of 200-700 nm is applied to the first layer. In an 
sequencing as the cell beings to rapidly proliferate (to especially preferred embodiment, the wavelength of the 
understand tumor formation); Incyte Pharmaceutical's ultraviolet light applied is in the range of 2 6 e 2 6 5  nm. In an 
disease-specific chips for drug design. Also, massively especially preferred embodiment, the first layer is positioned 
parallel, quick, sensitive and accurate bio-chip methods may on a first side of the second layer, and said measuring step 
boost the Human Genome Project. ,, measures photoluminescence from a second side of said 
d d  
H ~ ~ ~ ~ ~ ~ ,  mymetr ix> approach tags unknown to-be- second layer. In a further embodiment, said second side is 
sequenced DNAwith a fluorescent dye-altering the sample opposite said first side on said second layer. In another 
so that it generally cannot be reused for other tests, d s o ,  embodiment that is preferred, said first layer is positioned on 
because the Affymetrix chip at each pixel has about at least a first side of said second layer, and said measuring step 
a 5% error margin, the chip includes many repeated pixels, 60 measures photoluminescence reflected from said first side of 
to manage the error margin. The fabrication process for said second layer. 
Affymetrix' chip is expensive, requiring lithographic tech- In another preferred embodiment, the invention provides 
nique. a tagging-free sensor comprising a first layer including a 
DNA sequencing and other protein identification single stranded nucleic acid sequence and a second layer 
techniques, especially speedy parallel approaches, have 65 including a ~hotoluminescent material. 
important practical applications, such as disease diagnosis, In another preferred embodiment, the invention provides 
drug design, genetic and cancer screening, deciphering and an apparatus for tagging-free detection of binding of 
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molecules, comprising: a light source; a sensor having a said matrix material. In an especially preferred embodiment, 
nucleic acid layer and a photoluminescent layer; and a the second layer comprises polystyrene. In an especially 
photoluminescence detector. In especially preferred preferred embodiment, the second layer comprisesphotolu- 
embodiments, the light source is an ultraviolet light source, minescent particles in a polymer matrix. In a further Pre- 
an infrared light source, or a visible light source. In other s ferred embodiment, the ~hotoluminescent particles may be 
especially preferred embodiments, the detector is a light Or undO~ed  the group 
detector in the infrared to ultraviolet range. Where an consisting of group 11 and group VI. In another preferred 
ultraviolet light source is used, the ultraviolet light source in embodiment, as such a compound is wed doped Or undoped 
a particularly preferred embodiment provides ultraviolet zinc sulfide. Another especially preferred embodiment is one 
light at a range of about 260-265 nm. 10 in which the second layer comprises a nanocomposite. In a further preferred embodiment, the second layer comprises a 
In preferred the provides thin-film or a support, In another preferred embodiment, the 
a making a tagging-free second layer comprises a polymer, In another preferred 
contacting a single stranded nucleic acid sequence with a embodiment, the second layer has fluorescence when photoluminescent material. Aparticularly preferred embodi- excited by light with a wavelength in the 200-700 nm range, 
ment of such an inventive method includes devositinp. 1s 
- 
photoluminescent material on a substrate to form a surface, BRIEF DESCRIPTION OF THE DRAWINGS 
and thereafter modifying the surface by ion exchange treat- The foregoing and other objects, aspects and advantages 
merit with a metal salt, followed by ion-embedding, fol- will be better understood from the following detailed 
lowed by exposing the ion-embedded material to reactive description of the preferred embodiments of the invention 
media to form photoluminescent particles. 20 with reference to the drawings, in which: 
In the above-mentioned methods, products and FIG. 1 is a flowchart depicting a method according to the 
apparatuses, a particularly preferred embodiment of the present invention. 
invention uses DNA, RNA andlor PNA as the single FIG. 2(a) is a cross-sectional view of a device according 
stranded nucleic acid. In an especially preferred to the invention, 
embodiment, the first layer comprises an ssDNAmonolayer. 25 FIGS, 2(b) and q c )  are enlarged views of part of FIG, 
1n a ~ a r t i c u l a r l ~    referred embodiment, the sensor corn- 2(a), with FIG. 2(b) showing unbound single stranded prises ssDNA as said first layer grafted Onto the nucleic acid material according to the invention and FIG. 
layer. 2(c) showing bound nucleic acid material according to the 
In a preferred embodiment, the nucleic acid sequence is 30 invention. 
between 5 and 200 base pairs. In an especially preferred FIGS. 3(a), (b) and (c) together are a series of cross- 
embodiment, the sequence is about 25 base pairs. Another sectional views showing probing according to the invention. 
particularly preferred embodiment provides a discontinuous FIGS. 4(a), (b), (c) and (d) depict device fabrication with 
first layer comprising different nucleic acid sequences in nanocomposite formation according to the invention, 
different sections of said first layer. 
35 FIG. 5 shows an Atomic Force Micrograph of a nano- 
Further, another preferred embodiment of the invention compos~te structure according to the invention, 
provides a tagging-free method to detect binding of FIGS, 6(a) and 6(b) show an optical micrograph of a 
antigens, the steps (A) providing a selectively modified polystyrene surface according to the 
comprised of a first layer including an antibody and a second invention, layer including a photoluminescent material; (B) exposing 40 FIG. 7 shows fluorescent spectra from polystyrene used in 
said sensor to a biological sample for suficient time for said 
a photoluminescent-polymer containing embodiment of the 
antibody to bind to an antigen of interest in said biological invention. 
sample; (C) measuring photoluminescence from said sensor. 
In a particularly preferred embodiment, the first layer is a monolayer P ~ ~ Y ~ ~ Y ~ ~ ~ ~ ~ P ~ ~ Y ~ ~ ~ ~ ~ ~ ~ ~ ~  
discontinuous and comprises different antibodies. block copolymer spheres on an exemplary silicon surface 
45 according to the invention. In another preferred embodiment, the invention provides 
an apparatus for tagging-free detection of antibody binding, is a graph etching polybutadiene as 
comprising: a light source; a sensor having a first layer a time for an c O ~ O 1 ~ -  
including an antibody and a second photoluminescent layer; according to the present invention. 
and a light detector. FIG. 10 is a graph of the effect of surface treatment on 
Additionally, preferred embodiment of the inven- water, for lo 
tion provides a tagging-free sensor comprising a first layer the present invention. 
including an antibody and a second layer including a pho- FIG. 11 is a field emission micrograph of ZnS nanopar- 
toluminescent material. In a particularly preferred ticles On a 
embodiment, the first layer is discontinuous and comprises 55 according the present invention. 
different antibodies. In another especially preferred FIG. 12 shows ~hotoluminescence spectra for ZnS- 
embodiment, different known antibodies are included. containing materials according to the present invention. 
Further detailed embodiments of the above-mentioned FIG. 13 shows a top view of a bio-chip according to the 
inventive methods, products and apparatuses are as follows. invention 
Another particularly preferred embodiment of the inven- 60 FIGS. 14(a), (b) and (c) are a series of ~ross-sectional 
tion in the second layer uses aromatic polymers, doped or drawings showing fabrication of a polymer blob1 
undoped metal oxides, sulfides, selenides, arsenides, nano~article anbodiment of the invention. 
tellurides, andlor nitride and phosphide nanocomposites. In FIGS. 15(a)<g) show an exemplary process flow for 
another preferred embodiment, the second layer may com- making a nanoparticle array according to the invention. 
prise a matrix material, with said photoluminescent material 65 FIG. 16(a) shows an exemplary structure of a 
associated with said matrix material. In a further preferred nanoparticle/polymer blob bio-chip according to the inven- 
embodiment, said photoluminescent material is embedded in tion before use. 
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FIG. 16(b) shows the structure of FIG. 16(a) after the After the exposure procedure, an observation or measure- 
single stranded nucleic acid has hybridized with a comple- ment 200 is carried out, to observe or measure change (if 
mentary base sequence to form a double stranded nucleic any) in photoluminescence. For example, when providing 
acid. single stranded nucleic acid on a bio-chip, the bio-chip may 
FIGS, 17(a)-(c) show a reading method according to the s be illuminated with light at a wavelength at which the single 
invention for the device of FIGS, 16(~)-(b), in which uv stranded nucleic acid and the double stranded nucleic acid 
light is incident at an angle on the sample and the lumines- differentially absorb. Depending on what has occurred in the 
cent visible radiation from nanoparticles is recorded. exposure process, no change 210 may be measured1 
observed, or change 220 may be measuredlobserved. If no 
DETAILED DESCRIPTION OF THE 10 change 210 is found, it can be concluded that the sample 
PREFERRED EMBODIMENTS OF THE lacks a sufficiently complementary material to bind to the 
INVENTION known single stranded nucleic acid sequence. 
In a first preferred embodiment, of which FIG. 1 is If change 220 is found, it can be ~ ~ n c l u d e d  that a 
exemplary, the invention accomplishes nucleic acid (such as sufficiently complementary material in the sample has bound 
DNA, RNA or PNA) or protein sequence analysis without 15 to the known single stranded nucleic acid sequence. From 
tagging (such as fluorescent dye tagging), and provides the identity of the known single stranded nucleic acid 
products and apparatuses useable for such tagging-free Sequence, the likely identity of the complementary bound 
sequencing, ~ i ~ d i ~ ~  of molecules to a single stranded material can be inferred. The amount of change 220 will 
nucleic acid sequence can be detected without using con- vary depending upon the degree of complementarity 
ventional tagging, ~h~ invention uses a material that is 20 between the single stranded DNA and the biological mate- 
photoluminescent, which broadly includes a material that rial. The change 220 is a function of the change in photo- 
glows at any wavelength or that luminesces because of luminesce that can be measured from a support underlying 
photons. The invention uses application of light, and the the single stranded DNA. As more and more biological 
light input may be ultraviolet, visible, infrared or other light, material from the sample is bound to the single stranded 
without limitation. 25 DNA, greater and greater differences in the detectible lumi- 
In an exemplary embodiment of such an inventive nescence will result because of changes in the physical 
tagging-free method, a single stranded nucleic acid material characteristics of the nucleic acid between its single stranded 
of known sequence is provided. Examples of the single and bound state. 
stranded nucleic acid material are DNA, RNA and PNA. The In a preferred embodiment of the invention, a known 
single stranded nucleic acid sequence may be of any length, 30 single stranded nucleic acid sequence is provided on a 
with a preferred example being about 25 bp; however, the substrate, probe, bio-chi~ or other solid product, and the 
single stranded nucleic acid could range from 5 to 200 bp. biological sample is contacted in liquid form with the solid 
As seen with reference to FIG. 1 of an exemplary detec- product. In other embodiments of the invention, the 
tion system according to the invention, a measurement or unknown Or tO-be-sequenced may be 
observation 100 optionally may be made for a known single 35 provided 011 a substrate, probe, bio-chip or other solid 
stranded nucleic acid, alone. A numerical measurement is product and contacted with a liquid probe comprising sensor 
not necessarily required, and a baseline measurement in the particles each a sing1e stranded nucleic 
nature of a calibrating measurement or observation is within acid sequence attached to a photoluminescent material. 
the present invention. The present invention is based on 40 The inventive methods and products may be used to 
differential (rather than absolute) measurements or observa- sequence nucleic acid molecules (such as DNA, RNA or 
tions. In some embodiments, measurement or observation PNA) or other proteins. For example, one or more specific 
100 may be eliminated. DNA fragments (i.e., a gene) of unknown identity and 
After measurement/observation 100, the known single Sequence may be analyzed. The source materials for a 
stranded nucleic acid sequence is then exposed to a biologi- 45 biological sample to test are not particularly limited and may 
cal sample, such as a sample containing biological material be any nucleic acid or protein-containing biological mate- 
for which information is desired as to whether material rials (such as blood, tissue, fingernail clippings, etc.). ~ a w  
complementary to the known single stranded nucleic acid biological material, such as blood, generally may be Pro- 
sequence is contained therein. For example, the sample may cessed into testable fragments and Put into solution by 
comprise denatured DNA, RNA or PNA of unknown iden- so in the art. 
tity. The single stranded nucleic acid sequence used in the 
F~~ contacting the sample with the single stranded nucleic present invention is not particularly limited in the form in 
acid, known methods may be used, such as providing the which it is used, and a form such as a monolayer may be 
single stranded nucleic acid on a bio-chip and pipetting a used. A monolayer is particularly preferred. 
small amount of the sample solution into a well in the ss In a preferred embodiment, the single stranded nucleic 
bio-chip. The conditions of contacting the biological sample acid of the present invention is attached to a photolumines- 
with the known single stranded nucleic acid material are cent material. A preferred example of the attachment is by 
those permitting binding of the known single stranded grafting. "Grafting" may include covalently bonding a por- 
nucleic acid material with at least one protein or nucleotide tion of the single stranded nucleic acid to the photolumi- 
in the biological sample to form a complex, such as hybrid- 60 nescent material (e.g., by an amine linkage from lysine or 
izing conditions. Hybridizing conditions are known to those histidine), or it may include physical adsorption on the 
working in the art. Upon such exposure of the known single photoluminescent material, or other joining mechanism that 
stranded nucleic acid sequence to the biological sample, associates the single stranded nucleic acid and the photolu- 
binding, hybridizing and formation of a complex occur if minescent material in a manner which leaves a portion of the 
complementary material is contained in the biological 65 single stranded nucleic acid free to bond to other biological 
sample. Software is known to optimize hybridizing materials of interest. Examples of the photoluminescent 
conditions, by varying temperature, salt concentration, etc. material include, without limitation, an optically active thin 
US 6,706,479 B2 
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film, aromatic polymers, matrix materials that include metal luminescent at the excitation wavelength. FIG. 2(b) shows 
oxides or sulfides such as ZnS doped with Mn, etc. an enlarged view of part of FIG. 2(a), showing each single 
By way of non-limiting example, in an embodiment in stranded nucleic acid sequence 3a of which layer 3 is 
which a single stranded nucleic acid monolayer is grafted to comprised. In one example of using a device according to 
an optically active thin film, when the single stranded 5 the invention, and with reference to FIG. 2(c), the device is 
nucleic acid monolayer is exposed to light, the amount of exposed to biological sample material complementary to 
emitted light from the attached optically active thin film single stranded nucleic acid layer 3 such that conversion of 
depends on absorption by the single stranded nucleic acid single stranded nucleic acid sequences 3a to a double 
layer. When the single stranded nucleic acid layer comes in stranded nucleic acid form 33 occurs by binding with a 
contact with a complementary molecule, the single stranded lo complementary sequence 3b in the sample, leading to 
nucleic acid layer binds to the complementary molecule, change in input (i.e., excitation) light incident into the 
particularly, s s ~ ~ ~  converts to d s ~ ~ ~ ,  ~h  binding of the photoluminescent layer. The change in the incident light to 
single stranded nucleic acid causes the intensity of fluores- the ~hotoluminescent layer occurs due to the change in 
cent emission from the attached photoluminescent material reflectivity, absorption and scattering in the DNA layer as it 
to change, Where ssDNA is used as the single stranded converts from single stranded to double stranded. Thus, as a 
nucleic acid sequence, the observable fluorescence intensity l5 result of the binding that is conversion from single stranded to double stranded causes a change in the emitted photolu- for ssDNAversus dsDNA differs (because the absorption of 
minescent light intensity, This change in intensity of the is higher than dsDNA) in the 260 nm range. emitted photoluminescent light may be recorded, such as by 
rescence intensity is higher for the bound form (such as a a confocal microscope via a CCD camera, or by fiber-optics, 
converted dsDNA form) and this fluorescence intensity can 20 when an integrated optics approach is used, on-line mea- 
be observed to confirm the Presence of the complementary surement may be done during the hybridization process in 
sequence in the sample being tested. solution. On-line embodiments of the invention may be used 
For preferred materials according to the invention, e.g., to probe several genes simultaneously. 
polystyrene as the photoluminescent layer attached to In a preferred embodiment, an example of using a device 
ssDNA, the change in intensity of the photoluminescence 25 according to FIG. 2(a) is to provide ssDNA of known 
when the ssDNA converts to dsDNA differs by only about sequence as the single stranded nucleic acid on the device 
2-4%, so that studying the intensity would not be particu- and then to immerse the device in a solution of various 
larly dramatic. However, the present inventors have made unknown nucleic acid fragments. If there is a complemen- 
the important recognition that at 2 6 e 2 6 5  nm, not only the tary pair in the solution to the ssDNA on the device, 
absorption changes, but the refractive index changes, 30 hybridization will occur, and the ssDNA layer on the device 
because of which, the reflection (reflectivity) changes. The will convert from ssDNA to dsDNA. The invention permits 
amount of light reaching the polystyrene attached to the probing whether such a ssDNA dsDNA 
DNA may change by as high as ZOO%, for the following has to determine if the particular gene 
reasons. (complementary to known ssDNA on the device) exists in a biological sample solution. After reading the photolumines- 
DNA absorbs generally in the 260-265 nm range 35 cence for the device contacted with the sample, any bound 
and shining such On an materials from the sample can be loosened using techniques 
single stranded nucleic acid top layer results in absorption, known to those skilled in the art, and used in other testing 
reflection and scattering of the radiation. The left-over applications, 
transmitted radiation travels into the photoluminescent probing according to the invention is a measurement of 
material (such as polystyrene) causing it to give out radia- 40 change in photoluminescent light, as generally shown in 
tion at a different wave length. For example, the ~hotolu- FIG. 3, which relates to absorption for an inventive method 
minescence in polystyrene is at about 325 Dm. However, if according to FIG. 1 or inventive device according to FIG. 
the single stranded nucleic acid is bound SO that it becomes 2(a). With reference to FIG. 3,10 is the intensity of incident 
double stranded, the nucleic acid now absorbs, scatters and UV light at wavelength 265 nm (which is nominally the 
reflects a different amount of excitation wavelength, so that 45 absorption maxima of DNA). As the UV radiation is 
the amount of radiation experienced by a photoluminescent absorbed by the layer of photoluminescent material 2, the 
underlying layer differs from the case before binding photoluminescent particles emit visible light of intensity I,, 
occurred. Correspondingly the photoluminescent material I, or I, (which represent output intensity with no DNA graft 
gives out different photoluminescence intensity. The refrac- (i.e., DNA immobilized on the surface by at least one 
tive index changes, because of which, the reflection so covalent bond). If AI=I,-I, can be measured, the occurrence 
(reflectivity) changes. The amount of light reaching the of any hybridization reaction can be determined. The mea- 
photoluminescent material underneath may change by 200% surement of A1 can be performed in-situ in the solution 
or more. This is primarily due to the refractive index because the attenuation of I, due to absorption by the 
changes, because of which, the reflection (reflectivity) solution is constant and absorption by DNA and solution in 
changes, resulting in significant change with respect to the 5s the visible range is negligible. 
excitation light into the photoluminescent layer. Thus, study- Probing is depicted in FIGS. 3(a), (b) and (c), for the 
ing the amount of light from the photoluminescent material device shown in FIG. 2(a), in a fiber optics mode. I, in FIG. 
attached to the nucleic acid sequence provides a 3(a) is the photoluminescent intensity from optically active 
dramatically-different result for unbound versus bound layer 2 which in this example is a nanocomposite for 
nucleic acid sequences. 60 incident UV radiation, 10. The output intensity is reduced to 
Part of a bio-chip device that is an exemplary form of the I, on deposition of ssDNA3 (FIG. 3(b)) that further reduces 
invention is shown in FIG. 2(a). The device of FIG. 2(a), in UV radiation intensity incident on the optically active layer 
which optically active layer 2 comprises a photoluminescent 2 which is a nanocomposite. The intensity is further reduced 
material such as a nanocomposite or a photoluminescent when the ssDNA 3 is hybridized to form dsDNA 33 (FIG. 
polymer, may be used as follows The nanocomposite which 65 3(c)). The resultant photoluminescent intensity for the 
is a photoluminescent material may be provided in a matrix device according to FIG. 3(c) is I,. The relevant signal is 
material, with the matrix material optionally being photo- AI=12-I,. 
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The device of FIG. 2(a) optionally contains a reflective The single stranded nucleic acid in a preferred example 
layer such as gold layer 4 to enhance reflection, depending according to the invention is provided directly or indirectly 
on the end use. An optional reflective layer is preferably on a substrate 1 (FIG. 2(a)), the substrate not being particu- 
composed of a non-oxidizing material, of which gold is a larly limited. A reflecting or nonreflecting substrate may be 
preferred example. For example, as shown in FIG. 2(a), in s used, with a nonreflecting substrate being preferred. The 
the reflection mode, a layer of reflective gold 4 deflects the substrate 1 is not particularly limited and may be selected 
visible light produced by the photoluminescent material on based on the end-use probe method, A substrate is not 
the top side of the device. In the transmission mode required to be used in the present invention, (primarily for device characterization), the gold layer 4 of 
FIG, q a )  may be omitted and the visible p~oto~um~nescent  The photoluminescent material used in the invention is light may be detected on the other side of the sample, F~~ the 10 one which allows for observing the differential optical 
fiber optics mode, the gold layer 4 is not needed. activity when the DNA layer changes from single to double 
will be appreciated that sequencing according to the stranded nucleic acid sequences attached thereto. The pho- 
invention may be accomplished without any tagging of the toluminescent material for use in the present invention is any 
D N A ~ ~  be tested,  hi^ no-tagging feature will allow probing material that has different optical behavior when the single 
"beforen and "after" structure of DNA when subjected to a 15 stranded nucleic acid sequence attached thereto is unbound 
stimulus. For example, mutation of a gene due to UV or bound. Examples of such photoluminescent materials are 
radiation can be analyzed by the disclosed DNA chip. A aromatic molecules, such as polystyrene or other polymers 
probe according to the invention can probe kinetics of the (all aromatic polymers will exhibit photoluminescence). The 
mutation processes, location of the mutation and, impor- photoluminescent material used in devices according to the 
tantly (in the presence of a drug) evaluate the role of the 20 present invention obviates the need for photoluminescent 
drug-action on inhibition or acceleration of certain mutation tagging of biological sample material, The photolumines- 
processes. cent material (such as a polymer) to be used in the invention 
In an alternative embodiment, on-line integrated optics is selected so that when coupled with a single stranded 
may be used for DNA sequencing according to the inven- nucleic acid and its double stranded nucleic acid, different 
tion. 1n such a configuration, the device may be immersed in 25 photoluminescence is observed. Preferred photoluminescent 
a solution to measure both the identity of a specific gene materials are those which permit measurement of change in 
sequence and its hybridization kinetics. optical properties (i.e., complex refractive index) of the 
The in a further may be DNA as it changes from single to double stranded based on 
probe DNA and physical Or intensity of fluorescent emission from the photoluminescent 
treatment, which may be particularly for drug design 30 material attached to a nucleic acid, A preferred example of 
applications. 
a photoluminescent material for use in the present invention 
In DNA gene sequencing and is polystyrene, In the case of polystyrene coupled with 
other above-mentioned applications, other uses of the pho- 
toluminescent embodiments of the invention include appli- dsDNA or ssDNA, the absorption of ssDNA is higher than dsDNA in the 260 nm range, as may be observed from 
cations that may not be possible for devices using tagging 
35 intensity of fluorescent emission. 
methods. Further, because probes according to the invention 
may be large area devices, they may be used to separate The ~hotoluminescent material may be a nanocom~osite, 
known sequences from a mixture of single-strand nucleic a thin film loaded with sub-micron to nano-scale photolu- 
acid fragments at high precision and sensitivity, B~~~~~~ minescent particles, photoluminescent particles present in a 
sensors according to the invention may be made on-line, polymer matrix, Or any form photoluminescent 
sensors according to the invention have applications as 40 
on-line sensors for PCR. A nanocomposite for use in the invention preferably 
Devices comprising known single stranded nucleic acid comprises a polymer matrix encapsulating ~hotolumines- 
sequences for use in practicing the invention may be easily cent particles. The polymer matrix encapsulating the pho- 
fabricated, such as by the method shown in FIGS, 4(a) 45 toluminescent particles preferably is non-wetting such that 
through (d), ~~~~~l~~ of a device according to the present no nucleic acid adsorption other than the intended nucleic 
invention are a probe, a bio-chip, and other products useable acid attachment Occurs. 
in tagging-free sequencing. However, the surface may be selectively modified to 
F~~ use in the present invention, known single stranded allow for controlled nucleic acid grafting where the density 
nucleic acid sequences of length may be used, with so of molecules per unit area can be regulated. The attachment 
sequences of length from about 5 bp to about 200 bp being density preferably is low enough to avoid entanglement of 
preferred, and a sequence of about 25 bp being most adjacent chains and to allow for enough chain mobility for 
preferred. fast hybridization kinetics in solution. Preferably the density 
To make an exemplary device according to the present should be high enough for large change in complex refrac- 
invention, a single stranded nucleic acid sequence 55 tive index of the nucleic acid layer as it changes from single 
(preferably of known sequence) may be attached to a pho- stranded to double stranded. Polystyrene is an example 
toluminescent material. Attachment techniques for nucleic meeting these criteria. 
acids are known to those skilled in the art, including, without Preferred production methods for making devices accord- 
limitation, grafting, immobilization, electrovalent ing to the present invention include nanocomposite produc- 
attachment, covalent attachment, adsorption, van der Waals 60 tion procedures, self-alignment production procedures, 
attachment, etc. A preferred attachment mechanism is to nano-particle nano-array fabrication, and polymer blob/ 
covalently attach the nucleic acid sequence to the photolu- nano~article fabrication. 
minescent material. The attachment may be to directly attach An example of a nanocomposite production method is as 
the nucleic acid to the photoluminescent material or may be follows. As shown in FIG. 4(a), a nanocomposite film is 
to indirectly attach the nucleic acid to the photoluminescent 65 deposited on a rigid substrate (such as quartz or glass). To 
material, such as by interposing a linker or adhesion pro- deposit a smooth nanocomposite film shown in FIG. 4(b), an 
moter. in-situ three-step procedure is used, in which surface modi- 
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fication is followed by ion exchange with an appropriate In an embodiment in which a nanocomposite is used as 
metal salt. Next, the ions are subsequently embedded and the optically active layer 2, nanocomposite is formed on the 
then exposed to reactive media to form photoluminescent substrate. With reference to FIG. 1, ssDNA3 is grafted onto 
particles. During the ~article-embedding, the polymer sur- the nanocomposite. Preferably, the nanocomposite surface 
face is regenerated. The resultant structure is shown in FIG. 5 has been modified to allow for selective grafting thereon of 
4(b), with an ssDNA. The selective modification makes possible fabricat- (AFM) a nanOcOm~Osite structure ing a chip with large combinatorial of ssDNA that can be 
4(b) and according to the invention. The surface studied is used with simple micropipette dispensing, 
1 by 1 pm in tapping mode where both the topography (i.e. 
contrast is height) and damping (i,e,, contrast is local After any pre-grafting surface the 
hardness) are mapped. Comparing the three types of samples ssDNA3 layer is grafted, such as an 
clearly indicates that the particle are formed and the embed- linkage, such as difunctionalized organic compounds where 
ded particles are smaller than when the sulfonation takes One end react with a (surface polystyrene 
place without any diffusion of ions in the bulk, ~h~ fact that surface and the other end will attach to the 3' or 5' end of the 
the contrast is weaker for the embedded samples in the SSDNA. Examples of such organic compounds are commer- 
damping-map indicates that the particles are diffused inside cially available from Sigma Chemical Co. (St. Louis, Mo.1 
and the surface is nominally all polystyrene. and Molecular Probes, Inc. (Eugene, Oreg.). 
Returning to the operations of FIG. 4, the regenerated Preferably the functional groups are highly polar to 
surface (such as a polystyrene surface) shown in FIG, 4(b) achieve selectivity. By functionalizing discrete regions of 
next is selectively modified. The modification process pref- the polymer surface, the ssDNA can be grafted  l lo call^" 
erably is one that (i) is selective; (ii) permits the density of 20 confined to these regions. Preferably these regions are about 
functionalities on the surface to be regulated; and (iii) 100 by 100 microns so that it will be convenient to micro- 
provides a functionality such that the 31 or 51 end ofthe DNA pipette different ssDNAsequences in different surface modi- 
can be grafted. Simple plasma surface modification and fied regions. Thus an array of known ssDNA of various 
standard wet-surface modifications are known to those sequences can be deposited on the substrate 1. Because the 
skilled in the art, and either modification procedure may be 25 functionalized surface is highly polar and the polymer (such 
used as a surface treatment in the present invention. as polystyrene) is non-polar the DNA solution will self align 
~ ~ f ~ ~ ~ i ~ ~  to FIGS, 4(c) and 4(4 ,  DNA grafting may be on the functionalized regions due to surface tension. 
achieved by simple dispensing of ssDNA solution on the The ssDNA 3 that is grafted to the optically active 
functionalized area. As seen with reference to FIG. 6, the 30 polymer support is known. In a preferred embodiment, the 
droplet placement of different ssDNA solutions will be S S D N A ~  consists essentially of a monolayer of SSDNA. The 
self-aligning because the functional polar region is sur- known, grafted SSDNA 3 layer is available for binding with 
rounded by non-polar area. FIGS. 6(a) and (b) are optical molecules in a sample, such as hybridizing with Unknown 
micrographs of a selectively modified polystyrene surface ssDNA of a sample. The amount of emitted visible light 
according to the invention, The treatment time was 90 35 increases monotonically with the difference in reflectivity of 
seconds to ensure full modification, The droplets were the DNA layer as it changes from single to double stranded. 
formed by immersing the sample in water and air blowing The difference in reflectivity increases monotonically with 
the excess water. The scale indicator is 1 mm. change in complex refractive index from ssDNA to dsDNA. 
The self-alignment property is important in lowering the With reference to FIG. 1, the completed structure is 
cost of device fabrication. For example, if 100x100 pm 40 composed of two active layers: the top layer of grafted 
features at 1 mm period are made on a 25x25 mm substrate, ssDNA3 over a nanocomposite which is the optically active 
over 600 combinatorial can be simultaneously performed. layer 2 composed of photoluminescent particles. The nature 
Such deposition geometry can be performed by existing of the substrate 1 and other structure depends on the end-use 
dispensing systems common in microelectronics manufac- probe method, such as reflection mode or transmission 
turing or by micro-pipetting. The former is especially pre- 45 mode. 
ferred because the process can be expedited to the order of In an alternative embodiment of the invention, the opti- 
600 depositions in less than 100 seconds, with reliability. cally active layer 2 of the device of FIG. 1 instead of being 
FIG. 4 ( 4  shows the resulting surface with portions of two a nanocomposite is a photoluminescent polymer. Such a 
different types of ssDNA labeled ssDNA-1 and ssDNA-2. device may comprise a two-layer structure of a monolayer of 
FIG. 4 thus shows in-situ nanocomposite formation so ssDNA grafted onto a polymer thin film. The polymer thin 
according to the invention, starting with a highly smooth film may be one that is optically active such that it has 
polystyrene film deposited on a substrate. The film is then fluorescence when excited by radiation in the UV region, 
processed in three steps to produce photoluminescent preferably in the vicinity of 265 nm wavelength. For 
particles, with ZnS:Mn particles produced. The surface is example, the film may comprise polystyrene. The film may 
regenerated to produce polystyrene at the surface. The film 5s be deposited on an appropriate substrate depending on the 
is exposed to similar surface modification to functionalize intended end-use of the probe application. When the device 
the surface with acidic or basic moieties to attach to the 5' is exposed to UV light (-265 nm wavelength), the photo- 
or 3' end, respectively. active polymer film will emit light and the device may be 
As shown in FIG. 2(a), onto a substrate 1 optionally there used as set forth above for a device in which the optically 
is provided a gold electrode 4. After forming the electrode 60 active layer 2 is a nanocom~osite. 
4, a nancomposite comprising a polymer and photolumines- FIG. 7 shows typical fluorescent spectra from polystyrene 
cent particles is formed on the substrate 1 and electrode 4. under various conditions, when used in a device according 
A solution of polymer and photoluminescent particles may to the present invention. The dark curve with lower intensity 
be used. As examples of the photoluminescent particles may is the luminescence spectra of polystyrene coated with a 
be mentioned particles that when exposed to UV light (about 65 monolayer of ssDNA. The signal is intensified as the ssDNA 
265 nm wavelength), emit visible light (e.g., green), such as is converted to dsDNA. The peak intensity increases and the 
ZnS doped with Mn (i.e., ZnS:Mn). peak position is red-shifted. The difference in the intensity of 
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the fluorescent light before and after the conversion of expensive than lithography used in traditional methods of 
ssIlNA to dsDNA is defined as the contrast. The typical making DNA chips. Self-assembly is significantly less 
contrast shown in FIG. 7 is significant to decipher the expensive than traditional lithography-based DNAchip fab- 
ssIlNA to dsDNA transformation. This change in intensity rication methods. The self-alignment property of ssDNA is 
(i.e., contrast) of the emitted light may be recorded by s exploited, particularly, the functional polar region being 
several methods, such as (i) a confocal microscope via a surrounded by non-polar area. A reliable and relatively fast 
CCD camera; and/or (ii) a fiber-optic method. Afiber-optic manufacturing process may be accomplished, with many 
integrated optics approach will allow for on-line measure- depositions per minute possible. 
ment during the hybridization process in solution. Another alternative for making devices according to the 
Fabrication of a photoluminescent polymer-containing 10 present invention is to decorate nanoparticles on a block 
device may be as follows. A surface modification method copolymer template. A block copolymer comprising at least 
may be used, to allow for selective grafting of ssDNAon the two chain types is deposited on a substrate. The deposition 
polymer surface. Particularly, the selective modification is performed either by a solution process or a solid-forming 
allows fabricating a chip with large combinatorial of ssDNA process. The block-copolymer film is thermally processed to 
using simple micropipette dispensing. With reference to 15 separate the nanophase into discrete phases of the minority 
FIG. 2(a), the structure is composed of two active layers: the polymer. The structure of the discrete phase may be nano- 
top layer of grafted ssDNA over an optically active material spheres or cylinders with nano-scale diameter or other 
layer which in this embodiment is a fluorescent polymer (more) complex geometries depending on constituents of the 
layer. The nature of the substrate and other structure depends block copolymer. The important property of the film is a 
on the probe method. Two typical, but not limiting, probe 20 structure with phase-separated regions with characteristic 
methods are: (i) in the reflection mode, there is a third layer dimensions in the 5-500 nm scales. 
of reflective Au to deflect the visible light produced by the ~ ~ ~ t ,  the block copo~ymer is subjected to a surface 
~hotoluminescent material on topside of the device; (ii) in treatment that etches the surface to expose the discrete phase 
the transmission mode (such as primarily for device and in the same process activates the surface of the discrete 
characterization), the AU layer is not included and the visible 25 phase. However, the etched "rnatrixn polymer is not acti- 
photoluminescent light is detected on the other side of the vated. Subsequently, the structure is exposed to precursor 
sample. solution of inorganic and/or organo-metallic salts in a sol- 
The photoluminescent polymer may be composed of a vent system that does not attack the block copolymer. The 
fluroescent polymer or blend of a polymer with a photolu- salt(s) react with the activated surface to form a selective 
minescent dye. The ssDNA in the top layer are of known 30 deposition on the exposed surface of the discrete phase. 
sequence using an appropriate coupling linkage, such as Next, the deposited salt is reacted either with a reactive 
difunctionalized organic compounds where one end will gas or an active solution to form nanoparticles that are 
react with (surface modified) polystyrene surface and the specifically confined to the discrete phase regions. The 
other end will attach to the 3' or 5' end of the ssDNA. 35 sample optionally may be annealed before or after the 
It is preferred that the functional groups are highly polar nanoparticle synthesis step. Annealing embeds the resultant 
to achieve selectivity. By functionalizing discrete regions of nanoparticles in the discrete phase. The resultant structure is 
the polystyrene polymer, the ssDNA can be grafted locally defined as polymer blobs with nanoparticles. 
confined to these regions. It is preferred that these regions FIG. 14  shows a schematic of an exemplary process flow 
are about 100 by 100 microns making for ~ ~ n v e n i e n t  40 to make a chip according to the invention. Polymeric 
micro-pipetting of different SSDNA sequences in different "blobsn 6 ranging in size from about 1&1000 nm are 
regions. Thus an array of ssDNA of various sequences can produced on a substrate 1. The blobs may be on a random or 
be deposited on the polystyrene substrate. Because the periodic array (see FIG. 14(a)). Subsequently a single 
functionalized surface is highly polar and the polystyrene is stranded nucleic acid molecule 3a is attached (such as by 
non-~olar, the DNA solution droplets will self-align on the 4~ grafting) to each blob 6. Depending on the size of the blob 
functionalized regions due to surface tension. FIGS. 6(a) and the number of bases in the nucleic acid sequence 3a, the 
and 6(b) show such a surface modified polystyrene film number of nucleic acid sequences 3a per blob 6 may range 
according to the invention. After immersing the film in water from about 1 to 10, F~~ blob diameters below 50 nm and 
only the modified area has a wetting characteristic. nucleic acid molecules having more than 80 bases, the 
Preferably, the polymer for layer 2 is selected to be so number of nucleic acid molecules is likely to be one per 
non-wetting such that no DNA adsorption is possible. blob. 
However, selective modification of the surface may be used FIGS, 15(~)-(~)  show an exemplary method of fabricat- 
to allow for controlled ssDNA grafting where the density of ing a nucleic acid according to the invention, FIG, 
molecules per unit can be regulated. Thus, even if a drop is 15(a) shows, as starting materials, on a substrate 1 is 
too big, the drop will confine itself to the selectively ss provided a block copolymer 8 in which one of the blocks 8B 
modified area. The graft density preferably is low enough to is a diene polymer that may be etched by an oxidation 
avoid entanglements of adjacent chains and to allow for process such as ozone or oxygen plasma. The other polymer 
enough chain mobility to allow for fast hybridization kinet- segment 8 ~ i ~  an ozone resistant polymer, polymer segment 
its in solution. Also, the density preferably is high enough 8B is the majority phase and polymer segment 8A(shown as 
to result in a large absorption by the DNA layer. One 60 spherical) is the minority phase. The composition is such 
exemplary polymer that fits these criteria 1s polystyrene. that the minority phase 8A separate to form spheres or 
FIGS. 6(a) and 6(b) show selective modification of sphere-like particles. It is preferred that the block copolymer 
polystyrene, with only the area exposed being wetting and 8 is fairly monodispersed to have the spheres self assemble 
suitable for single stranded nucleic acid strands to graft in a nominally regular lattice. an example, minority phase 
thereto. 65 polymer segment 8A may be polystyrene (PS) or poly 
Thus, a DNA chip according to the invention may be (methyl methacrylate) (PMMA) and majority phase 8B may 
fabricated using self-assembly techniques, which are less be polyisoprene or polybutadiene. 
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In FIG. 15(b), the block copolymer thin film 8 is spin cast Using any of the above-mentioned production methods, 
and annealed to form a monolayer of the microphase sepa- or any other suitable method, a bio-chip such as that of FIG. 
rated spheres. Then the matrix is etched by ozone or plasma 13  with an array of pixels 5 may be made. In a preferred 
to form isolated A-spheres 8a. Subsequently the sphere 8a is embodiment, the invention provides a DNA chip for pho- 
annealed above the glass transition temperature of the ~ 0 1 ~ -  5 toluminescent measurements at lo4 pixels (sites). The same 
mer form polymer (see 15(~)) .  In the next pixel may be repeated 100 times, at different locations, so 
step, the surface l a  of the substrate 1 is modified by anionic that repeated measurements may be made, to establish 
groups (see 15(d)) provide 88a. The statistical significance. For example, a lo4 pm2 size probe 
group used for such modification may be a strong anion that with shown, for example, as in FIG, 16(a) may be 
forms a when an Zn, Cd, fabricated, Each substrate may have a different single 
Pb or Hg salts. Upon annealing (see FIG. 15(e)) to form 10 
annealed blobs and exposure to H2S, II-VI calcogenid stranded nucleic acid probe. The UV light input and visible 
nanoparticles 9 will be formed (see FIG, 1 5 0 )  in the blobs light Out may be in to the substrate a 
sac, T~ provide the highest p~oto~uminescence, a typical integrated optical method, known to one skilled in the art. 
nanoparticle may be doped, such as, ZnS:Mn or ZnS:Ag. For example, optical fibers may be used. To improve the 
The former has highest photoluminescence intensity around signal to noise ratio the incident beam may be n~odulated 
265 nm which is close to the maximum absorption of nucleic and the output signal may be locked-in at the same fre- 
acids in the UV-region. quency. Such an integrated approach advantageously builds 
In the next step, the blob surface is modified again by wet a" on-line sensor where each fiber or fiber bundle has a type 
chemistry, plasma or corona to form moieties that can react of single stranded nucleic acid different from the other fiber 
with the 3, or 5, end of the nucleic acid chain, F~~ example, bundle. In this way, several single stranded nucleic acids 
if a hydroxyl group is formed by water plasma, the phos- 20 may be probed in a mixture simultaneously, such as in a 
phate end will react to form a covalent bond. Thus the multi-gene probe. 
nucleic acid chain will be grafted on the polymer blob A"digital" approach may be used in fabricating a bio-chip 
surface. Depending on the size of the nucleic acid, one or according to the invention, in which the probe sites are 
more chains can be grafted per blob. For a long chain over arranged on a periodic array with 1@50 nm scale period- 
50 bases, only one chain may be grafted per blob due to the 25 icity. A discrete, periodic arrangement will allow for abso- 
lateral size of the chain (see FIG. 16(a) which is an enlarge- lute nucleic acid count with high sensitivity and accuracy, 
ment of FIG. 15(g)). FIG. 15(g) and FIG. 16(a) show a final and low noiselerror that otherwise arises due to overlap of 
structure with a nanoparticle 9 in a blob 88d and the single signals from adjacent fragments in an "analog" method. 
stranded nucleic acid 3a graft. When such a surface is Compared to conventional bio-chip technologies, the inven- 
exposed to a mixture of single stranded nucleic acid 30 tive methods and products are useable with sample sizes 
fragments, the probe single stranded nucleic acid grafted on lo3-lo4 smaller. Also, the array fabrication may be based on 
the substrate will act like chemical tweezers to pick the a relatively inexpensive and highly parallel self-assembly 
complementary single stranded nucleic acid for hybridiza- approach instead of expensive lithographic techniques. 
tion. The resultant double stranded nucleic acid 33 on the The present invention has been discussed above particu- 
surface is shown in FIG. 16(b). Nanoparticles 9 generally 35 larly with regard to nucleic acids. Because the complex 
have a diameter in the range of 2-30 nm. Blobs 88d refractive index of the proteins also changes significantly in 
generally have a diameter of about 10-100 nm and pitch the UV range as it reacts with other proteins or alters 
about 10-100 nm. structure, a sensor or analytical device can be fabricated to 
For a device such as that of FIGS. 16(a)<b), a reading probe antigens and proteins as discussed above with regard 
method may be provided as follows. The reading of the to nucleic acids. Thus, an antigen-antibody sensor may be 
hybridized sites indicating a match is explained in FIGS. 40 provided. In such a device, the desired antibody replaces the 
17(a)-(c). When the chip with no nucleic acid is exposed to single stranded nucleic acid. Because no tagging is required, 
UV light (excitation light or probe light) the photolumines- such a device can be a highly sensitive sensor to detect small 
cent nanoparticles radiate I, in the visible range (see FIG. levels of antigens and proteins that are airborne or in liquid. 
17(a)). The visible light is equal in all directions. To avoid The principle of detection and device fabrication is as set 
any interference from the probe (i.e., UV) light, the lumi- 45 forth regarding the use of single stranded nucleic acids. 
nescence intensity I, is recorded in the normal direction. Non-limiting examples according to the invention are as 
When the nucleic acid chip with single stranded nucleic acid follows. 
3a is exposed, the intensity changes from I, to I, because the 
light incident on the nanoparticle changes due to change in EXAMPLE 1 
the optical property (i.e., absorption, reflectivity or 50 A block copolymer film of polystyrene (PS)/ 
scattering) of the top surface due to attachment of the single polybutadiene (PB) was deposited on a silicon (Si) surface 
stranded nucleic acid (see FIG. 17(b)). The intensity further to produce a highly ordered discrete phase of PS spheres. 
changes to If when the single stranded nucleic acid hybrid- See FIG. 8. The structure was then exposed to plasma 
izes to form double stranded nucleic acid 33 (see FIG. containing water vapor to etch the butadiene and modify 
17(c)). The change from FIGS. 17(b) to 17(c) is due to the 55 polystyrene. FIG. 9 shows a typical etch curve (for 
change in complex refractive index of DNA as it converts polybutadiene) indicating the amounts of etch as a function 
from single to double stranded. Thus the amount of photo- of exposure time. To confirm that the surface modification is 
luminescent light from the nanoparticle will change accord- indeed selective, pure polymer PS and PB were exposed to 
ingly in the three cases shown in FIG. 17. The contrast, 1,-1, similar treatment. The wetting angle for water, in FIG. 10, as 
is proportional to the number of single stranded nucleic acid a function of plasma exposure clearly indicates that PS is 
molecules per unit area. Hence a calibration of the sites 60 modified and becomes highly polar (i.e., wetting) however, 
available for hybridization will be provided. The contrast PB is not modified in any significant manner. Particularly, 
IfIo=,AI is proportional to the number of single stranded FIG. 10 shows that the contact angle of water decreases on 
nucleic acids hybridized to double stranded. PS but remains high for PB as the treatment time increases. 
The production methods discussed above are by way of The activated surface is immersed in Zn-salt solution and 
example, and are not limiting. For example, where ssDNA 65 exposed to H2S to form ZnS. FIG. 11 shows a typical 
is mentioned, the methods may be applied for other nucleic field-emission scanning electron micrograph (SEM) where 
acids. the PS spheres are bright compared to the PB matrix. The 
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brightness of PB is attributed to presence of high atomic acid to bind to an untagged material of interest in said 
number Zn compared to low atomic weight materials (i.e., C biological sample; 
and H) in the matrix. In FIG. 11, ZnS nanoparticles on a (C) applying light to said sensor; and 
block copolymer are shown, and notably the PS discrete (D) measuring photoluminescence from said sensor, 
islands are spherical and bright compared to the matrix 5 wherein photoluminescence measured in said step of 
indicating that the ZnS is confined only to PS. The random exposing is indicative of binding of said untagged 
arrangement of PS spheres is due to over-etching of PB. single stranded nucleic acid to said untagged material 
Photoluminescence (PL) spectra of the resultant sample of interest. 
shown in FIG. 12, which shows photoluminescence from 2. The tagging-free method of claim 1,  wherein the single 
zns particles, indicate that the typical emission peak at -420 stranded nucleic acid is selected from the group consisting 
nm is strongly blue shifted by over 100 nm indicating the DNA, RNA and PNA. 
presence of nanoparticles of ZnS. The strong blue shift is an 3. The tagging-free method of 'laim wherein said 
indication of quantum confinement effects indicating a second layer comprises a matrix material, with said photo- 
nominal size of <3 nm ZnS particles. luminescent material associated with said matrix material. 4. The method of claim 3 wherein said vhotoluminescent 
EXAMPLE 2 material is embedded in said matrix mat&ial. 5. The tagging-free method of claim 1,  wherein the second 
Using self-assembled block copolymer monolayers and layer comprisespolystyrene. 
high anisotropic etching, a structure is made by grafting 6. The tagging-free method of claim 1,  wherein the second 
ssDNA fragments (x) on a nanoparticle coated polymer layer photoluminescent particles in a polymer 
blob. The blobs (made of polystyrene (PS)) are arranged 20 matrix. 
periodically on a (silicon) substrate. The periodicity and size 7. The tagging-free method of 6, wherein the 
of the blobs is in the 10-20 nm range (see FIG, 14(a)), The photoluminescent particles are Or undO~ed  
direct band gap semiconductor nanoparticles are embedded pounds from the group consisting of group '' and 
in-situ in the polymer to ensure nominally monodispersed group "I. 
size distribution and to simplify the process, The lumines- The tagging-free method of 7, Or 
cence excitation will be tailored to the maximum at -260 nm 2s undoped zinc 
(close to the absorption maxima of DNA), As the ssDNA is 9. The tagging-free method of claim 1,  wherein the second 
grafted, the luminescent light in the visible range will be layer comprises a nanocomposite. 
attenuated from I, to Ii, Thus by measuring the difference lo .  The tagging-free method of 'laim '3 wherein said light 
AI=IfIi as the probe sites with grafts are exposed to a is applied to said first layer of said sensor, and said light is 
ssDNA mixture the amount of y fragments can be quanti- 30 light with in the range of 20e700 
tatively calculated. The calibration constant relating A1 and 
number of y attached to the substrate is determined exactly The tagging-free method of wherein the 
since the number of sites are known, To achieve measur- wavelength of the ultraviolet light is in the range of 26e265 
able contrast, i.e., AI-10% change, the minimum ssDNA 
size is a 50 base pair sequence, For 50 base sequence ssDNA 3s 12. The tagging-free wherein the first 
on 20 nm pitch array, only one chain per blob is possible due layer comprises an monolayer. 
to lateral size of the gaussian chain (see FIG. 14(a)). A total 13. The tagging-free method of 'laim '3 wherein the 
array size of lo4 pm2 is sufficient to measure I,, Ii and If for second layer comprises a thin-fi1m Or a support. 
nanoparticle monolayers with a conservative quantum effi- 14. The tagging-free method of 'laim '3 wherein the 
ciency of 25% and detector acceptance angle of 30". This 4o second layer comprises a polymer. 
way, a sensitivity to measure 2,5x107 ssDNA (or -10 15. The tagging-free wherein the 
femotgram) per array is possible, By making an ensemble nucleic acid sequence is between 5 and 200 base pairs. 
with several arrays of different ssDNAgrafts and connecting 16. The tagging-free method of 'laim wherein the 
each array to a 100 pm diameter optical fiber, a parallel Sequence is about 25 base pairs. 
analysis of several fragments can be achieved. 17. The tagging-free method of claim 1, wherein the 
4s second layer has fluorescence when excited by light with a While the invention has been described in terms of its wavelength in the 200-700 nm range, preferred embodiments, those skilled in the art will recog- la, The tagging-free method of claim wherein the 
nize that the invention can be practiced with modification sensor comprises ssDNA as said first layer grafted onto the 
within the spirit and scope of the appended claims. second layer. We claim: 19. The tagging-free method of claim 1,  wherein said first l.Atagging-free method to detect the binding of untagged layer comprises a plurality of sections each of which corn- 
single stranded nucleic acid to an untagged material of prises a different untagged single stranded nucleic acid interest, comprising the steps of: sequence. 
(A) providing a sensor comprised of a first layer and a 20. The method of claim 1, wherein said first layer is 
second layer wherein said first layer comprises an positioned on a first side of said second layer, and said 
untagged single stranded nucleic acid and wherein said ss measuring step measures photoluminescence from a second 
second layer comprises a photoluminescent material, side of said second layer, 
and wherein said first layer and said second layer are 21. The method of claim 20, wherein said second side is 
separate layers, and wherein said second layer corn- opposite said first side on said second layer, 
prises material selected from the group consisting of 22, The method of claim 1, wherein said first layer is 
aromatic polymers, doped or undoped metal oxides, 60 positioned on a first side of said second layer, and said 
sulfides, arsenides, tellurides, and nitride and phos- measuring step measures photoluminescence reflected from 
phide nanocomposites; said first side of said second layer. 
(B) exposing said sensor to a biological sample for 
sufficient time for said untagged single stranded nucleic * * * * *  
